Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?

摘要

BackgroundEvidence is growing that low-dose aspirin used as an adjuvant treatment of cancer is associated with an increased survival and a reduction in metastatic spread. We therefore extended up to August 2017 an earlier systematic search and meta-analyses of published studies of low-dose aspirin taken by patients with a diagnosis of cancer.